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ABSTRACT
Biofilm Characterization and the Potential Role of eDNA in Horizontal Gene Transfer in
Hospital and Meat Isolates of Staphylococcus aureus and Their Biofilms
Ashley Ball
Department of Microbiology and Molecular Biology, BYU
Master of Science
Staphylococcus aureus is a pathogen responsible for a wide variety of life-threatening
diseases such as bacteremia, endocarditis, and pneumoniae. S. aureus has been a major concern
in recent years due to the rampant spread of antibiotic resistance. The ability of S. aureus to form
biofilms aids in the spread of antibiotic resistance as biofilms are a known hotspot for horizontal
gene transfer. Biofilms also protect cells from host immune responses and antibiotics, making
these infections very difficult to treat. The matrix of S. aureus biofilms can be made of
polysaccharides, protein, and DNA.
In these studies, we sought to elucidate how biofilm composition correlates with source
of isolation in S. aureus strains, the role of biofilm-related genes in biofilm composition, and the
potential role of biofilm eDNA in horizontal gene transfer. The composition and strength of
biofilms made by a variety of hospital and meat-associated strains of S. aureus was measured
using crystal violet (CV) staining and DNase or proteinase K treatment. Biofilm polysaccharide
concentration was also measured using the phenol sulfuric-acid assay. We found that biofilms of
hospital-associated isolates tend to have more protein and polysaccharides while those of meat
isolates contain significantly more DNA. We also investigated the effects that biofilm-related
genes have on biofilm formation and composition by analyzing specific transposon mutants of
genes suggested by previous studies to play a role in biofilm development. Transposon
insertions in agrA, atl, clfA, fnbA, purH, and sarA significantly weakened biofilms as compared
to a wild-type control, whereas the acnA insertion mutant produced a significantly stronger
biofilm. Biofilms formed from these mutant strains were treated (or mock-treated) with DNase
or proteinase K and tested with phenol and sulfuric acid to determine what role these genes play
in biofilm composition. We found that the atl and sarA insertion mutants produced biofilms with
greater polysaccharide concentrations than the wild-type.
Since many of the isolates produced biofilms composed of DNA, we investigated the
potential role of this extracellular DNA in horizontal gene transfer. Strains with complementary
antibiotic resistances and susceptibilities were paired together and co-cultured together in a
biofilm and plated onto double antibiotic plates to select for possible gene transfer. Putative gene
transfer was found to be largely biofilm dependent and enhanced with the addition of
subinhibitory concentrations of antibiotics added to the biofilm. Potential transformation was
also shown to naturally occur in many strains when naked DNA was added to a single strain
biofilm and was also aided with the addition of subinhibitory antibiotics.
Keywords: Staphylococcus aureus, antibiotic resistance, biofilm, horizontal gene transfer,
MRSA
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CHAPTER I: Research Introduction
Staphylococcus aureus Pathogenesis
Staphylococcus aureus is a common gram-positive bacterium frequently found in the
upper respiratory tract and on the skin (Foster 2002). S. aureus is the leading cause of surgical
site and soft tissue infections and can cause many life-threatening infections such as bacteremia,
pneumonia, osteomyelitis, and endocarditis (Olaniyi, Pozzi et al. 2016, Vella, Galgani et al.
2021). As a result, S. aureus causes around 20,000 deaths per year in the U.S. and has been
declared a priority pathogen by the World Health Organization (Kourtis, Hatfield et al. 2019,
Murray, Ikuta et al. 2022).
S. aureus has a wide array of virulence factors that allows it to survive and cause disease
within the human host (Liu 2009). The initial barrier to infection for S. aureus is colonization.
Colonization of the human nose requires S. aureus to adhere to nasal epithelial cells and fight off
host defenses and competing microorganisms (Liu 2009). S. aureus adheres and invades host
epithelial cells using a variety of microbial surface components recognizing adhesive matrix
molecules (MSCRAMM) such as ClfB and wall linked wall teichoic acid (WTA) (Wertheim,
Walsh et al. 2008). S. aureus must also compete with other bacteria for adhesion to the same host
receptor (Krismer, Weidenmaier et al. 2017). This can be done directly, through secretion of
antibacterial peptides like staphylococcin C55, and indirectly through activating host immune
cells, thus killing off bacteria that are not as adept as S. aureus at evading immune defenses
(Laux, Peschel et al. 2019). S. aureus expresses proinflammatory lipoproteins which activate the
Toll-like receptor 2, resulting in an inflammatory response and the production of antimicrobial
peptides by immune cells (Laux, Peschel et al. 2019).
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S. aureus also displays multiple mechanisms to evade host immune defenses. S. aureus
avoids opsonization by expressing clumping factor A, protein A, and a number of complement
inhibitors on its surface (DeLeo, Diep et al. 2009). These factors inactivate or prevent host
opsonins from binding or targeting S. aureus for phagocytosis (DeLeo, Diep et al. 2009). Toxins
are another important virulence factor in S. aureus, helping the pathogen to evade immune
defenses by lysing neutrophils (Otto 2014). Toxins such as alpha-hemolysin (Hla) and alpha-type
phenol soluble modulins (PSMα) have been shown to contribute significantly to neutrophil
killing and virulence in vivo (Greenlee-Wacker, DeLeo et al. 2015).
Bacterial survival within the human host is also dependent on the acquisition of nutrients,
particularly iron (Maresso and Schneewind 2006). There are two main mechanisms by which S.
aureus acquires iron in low-iron environments within the host: siderophore-mediated acquisition
and heme-iron acquisition. S. aureus secretes high affinity iron-binding siderophores,
staphyloferrins A and B being the most characterized (Balasubramanian, Harper et al. 2017).
These proteins capture extracellular iron bound to host glycoproteins by removing iron from host
proteins that sequester iron such as transferrin and lactoferrin. The captured iron is then
transported into the cell via ABC transporters (Courcol, Trivier et al. 1997). While siderophores
scavenge extracellular iron, the majority of iron is found as heme inside erythrocytes (Maresso
and Schneewind 2006). Heme-iron acquisition occurs through lysis of erythrocytes by
hemolysins and cytotoxins (Torres, Attia et al. 2010). After erythrocyte lysis, heme is captured
and taken up by the iron-regulated surface determinant (Isd) system (Maresso and Schneewind
2006).
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Antibiotic Resistance in Staphylococcus aureus
Antibiotic resistance is commonly found among S. aureus strains and has dramatically
increased over the years (Sakoulas and Moellering Jr 2008). Of high concern to public health is
methicillin resistant S. aureus (MRSA) which have a 60% higher mortality rate than methicillin
susceptible S. aureus (MSSA) (Murray, Ikuta et al. 2022). A study on the global burden of
antimicrobial resistance in 2019 found that MRSA caused more than 100,000 deaths that year
(Murray, Ikuta et al. 2022).
MRSA was traditionally only associated with hospital-associated (HA) infections;
however, MRSA has emerged as a widespread cause of community-associated (CA) infections in
the past few decades (Okuma, Iwakawa et al. 2002, Purcell and Fergie 2002, Chavez and Decker
2008). S. aureus is part of the normal human flora and is found in approximately 30% of the
population’s nasal passages (Kluytmans, Van Belkum et al. 1997, Gorwitz, Kruszon-Moran et al.
2008). Asymptomatic nasal carriers of S. aureus are at higher risk of infection and are an
important source of spread of CA-MRSA strains among individuals (Kluytmans, Van Belkum et
al. 1997, Gorwitz, Kruszon-Moran et al. 2008). CA-MRSA infections are a major concern as
they have appeared in otherwise healthy, non-immunocompromised individuals and are
associated with higher virulence than HA-MRSA (De Lencastre, Oliveira et al. 2007, Chambers
and DeLeo 2009, Skov, Christiansen et al. 2012) .
S. aureus’s ability to quickly develop and spread resistance to antibiotics has led to the
formation of multidrug resistant superbugs (Saxena and Gomber 2010). More than 50% of
MRSA isolates are resistant to macrolides, lincosamides, floroquinolones, and aminoglycosides
(Archer 1998, Mancini, Verdini et al. 2016). As a result, vancomycin has been largely used to
treat MRSA infections for the last two decades (Appelbaum 2006, McGuinness, Malachowa et
3

al. 2017). Some strains, however, have developed intermediate resistance (VISA) and even highlevel resistance (VRSA) to vancomycin (Tenover, Weigel et al. 2004, Appelbaum 2006,
McGuinness, Malachowa et al. 2017). VRSA and VISA infections have further complicated
treatment options, and the possibility of the spread of vancomycin resistance to the community is
a major concern for the healthcare community (Appelbaum 2006, Gardete and Tomasz 2014).
Because of the high selective pressure for antibiotic resistant bacteria, antibiotic usage is
limited in humans, however, antibiotics continue to be widely used in agricultural settings
(Khachatourians 1998). Antibiotics are given to animals not only for the treatment of infections
but also for disease prevention and growth promotion (Wise, Hart et al. 1998). In this
environment with continuing exposure to antibiotics, there is high selective pressure for
antibiotic resistance to develop and possibly spread to human strains (Ramchandani, Manges et
al. 2005, Landers, Cohen et al. 2012, Cuny, Wieler et al. 2015). Animal to human transmission
of resistant strains has been documented and can have a detrimental impact on public health if
these strains enter the community and health care settings (García-Álvarez, Holden et al. 2011,
Paterson, Harrison et al. 2014, Cuny, Wieler et al. 2015).
The rise and spread of multidrug resistance in S. aureus have increased mortality and
duration of S. aureus infections while limiting treatment options (Appelbaum 2006, Saxena and
Gomber 2010). MRSA strains have shown a greater propensity to pick up additional resistance
genes than MSSA, making it crucial to investigate how resistance genes transfer in MRSA and
environments that may promote gene transfer. MRSA strains are also associated with higher
mortality rates and longer, more chronic infections than MSSA (Cosgrove, Qi et al. 2005,
Organization 2014). The increased duration of MRSA infections means an increased financial
burden for treatment as well. One study found the increased attributable cost of MRSA versus
4

MSSA was approximately $4000 per infection (Cosgrove, Qi et al. 2005). As antibiotic
resistance becomes more prevalent in S. aureus, exploring additional treatment options and
studying the mechanisms by which S. aureus develops and spreads antibiotic resistance becomes
more vital.
Mechanisms of Antibiotic Resistance in Staphylococcus aureus
Cell Wall Inhibitors
Some of the earlier antibiotics introduced were cell wall inhibitors with the introduction of the βlactam antibiotic, penicillin, soon followed by methicillin and oxacillin (Walsh and Amyes 2004,
Peacock and Paterson 2015). Penicillin-binding proteins (PBPs) are essential proteins in S.
aureus that crosslink peptidoglycan in the cell wall, allowing for a strong cell wall structure
(Llarrull, Fisher et al. 2009). β-lactam antibiotics bind to PBPs, disrupting peptidoglycan crosslinking during cell wall synthesis. This makes the cell wall susceptible to osmotic changes,
resulting in bacterial lysis (Llarrull, Fisher et al. 2009, Saxena and Gomber 2010, Peacock and
Paterson 2015). There are several different PBPs in S. aureus, and while almost all are inhibited
by β-lactams, PBP2a is a unique transpeptidase that is not inhibited by β-lactam antibiotics, and
therefore, allows for resistance to these antibiotics (Walsh and Amyes 2004, Peacock and
Paterson 2015). PBP2a is encoded in the mecA or mecC gene which results in resistance to βlactam antibiotics (Llarrull, Fisher et al. 2009, Fisher and Mobashery 2016). The mecA/mecC
gene is located on the Staphylococcal chromosomal cassette mec (SCCmec) (Liu, Chen et al.
2016). Besides mecA/mecC, the SCCmec also encodes site-speciﬁc recombinase genes ccrAB
or/and ccrC which mediate excision and integration of the SCCmec into the S. aureus genome
(Liu, Chen et al. 2016).
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Vancomycin is another cell wall inhibiting antibiotic that is used to treat MRSA
infections. It is a glycopeptide that has high affinity for the dipeptide D-ala-D-ala component of
the bacterial cell wall precursor lipid II. Binding to lipid II prevents transglycosylation and
transpeptidation catalyzed by PBP2 and PBP2a (Münch, Engels et al. 2015). VRSA strains carry
the transposon Tn1546, acquired from vancomycin-resistant Enterococcus faecalis (Lowy 2003,
Sieradzki and Tomasz 2003). Tn1546 encodes the gene, vanA, a ligase that allows for the
formation of the dipeptide D-ala-D-lac that replaces the D-ala-D-ala lipid II dipeptide in
peptidoglycan synthesis (Périchon and Courvalin 2009). This substitution considerably decreases
the affinity of the lipid II for vancomycin, thus inhibiting antibiotic binding (Lowy 2003,
Appelbaum 2006, Périchon and Courvalin 2009).
Resistance in VISA is thought to mainly occur as a result of changes in peptidoglycan
synthesis. VISA strains synthesize extra peptidoglycan with increased quantities of D-alanyl-Dalanine residues. These residues bind vancomycin molecules and effectively sequester them,
thereby preventing them from reaching their bacterial target (Appelbaum 2006, Saxena and
Gomber 2010, Gardete and Tomasz 2014).
Inhibitors of Bacterial Translation
Macrolides, lincosamides, streptogramins, and tetracyclines are classes of antibiotics that
function via inhibition of protein synthesis (Saxena and Gomber 2010). Macrolides,
lincosamides, and streptogramins were first introduced in 1952, and are often grouped together,
collectively known as MLS (Saxena and Gomber 2010). They target the bacterial 50S ribosomal
subunit, thereby effectively inhibiting protein synthesis [5]. Like penicillin, soon after the
introduction of these antibiotics, resistance soon emerged and spread among S. aureus strains [5,
6].
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Bacteria resist MLS antibiotics in one of three ways: methylating or mutating of the
target site to block binding of the antibiotic to the ribosome, efflux of the antibiotic, or enzymatic
inactivation of the antibiotic (Walsh and Amyes 2004, Saxena and Gomber 2010). The erm gene
confers resistance to the macrolide, erythromycin (Stapleton and Taylor 2002, Walsh and Amyes
2004). Approximately 40 erm genes have been reported, but ermA, ermB, ermC and ermF, are
the genes most frequently involved in MLS resistance in S. aureus (Moosavian, Shoja et al.
2014). The erm genes encode the erm methylase which demethylates the single Adenine in the
23S rRNA, a part of the 50S ribosomal subunit, and thereby decreasing binding affinity of the
antibiotic (Dzyubak and Yap 2016, Munita and Arias 2016). Another important source for MLS
resistance in S. aureus is the plasmid-borne msr(A) gene. msr(A) encodes an ABC transporter
allowing for the efflux of the antibiotic (Moosavian, Shoja et al. 2014).
Tetracyclines also function by inhibiting protein synthesis, however, MLS antibiotics
bind to the 50S ribosomal subunit while tetracyclines bind to the 30S subunit (Walsh and Amyes
2004). Tetracyclines are broad-spectrum antibiotics and are now used as the second line of
treatment for MSSA infections after β-lactams (Trzcinski, Cooper et al. 2000). S. aureus acquires
tetracycline resistance through either efflux of the antibiotic mediated by tetK and tetL genes on
a plasmid or through ribosomal protection mediated by tetM or tetO genes located on a
transposon or the chromosome (Trzcinski, Cooper et al. 2000, Chopra and Roberts 2001, Munita
and Arias 2016). Studies have shown that tetM is the major determinant of resistance in MRSA
while tetK is predominantly found in MSSA isolates (Trzcinski, Cooper et al. 2000, Munita and
Arias 2016).
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Horizontal Gene Transfer in Staphylococcus aureus
The propensity of S. aureus to share genes through horizontal gene transfer (HGT) allows for
the rapid spread of antibiotic resistance that is characteristic of S. aureus (Haaber, Penadés et al.
2017). HGT occurs in 3 different ways: transduction, conjugation, and transformation.
Transduction occurs when foreign DNA is introduced into a cell by a virus. S. aureus strains
commonly contain a few bacteriophages integrated in their genome as prophages which can
excise either spontaneously or by induction through activation of the bacterial SOS response
(Brown, Brown et al. 1972, Krausz and Bose 2014). After induction, the prophage enters the
lytic cycle where bacterial DNA, instead of phage DNA, may be packaged into the phage capsid
and then injected to another cell (Lindsay 2014). Up to 45 kbp of bacterial DNA is packaged into
the phage capsid during transduction (Haaber, Penadés et al. 2017). Because of the size of some
mobile genetic elements, such as SCCs which can be up to 60 kb, transduction efficiency is
limited especially of mecA and other resistance genes located on large plasmids or SCCs
(Haaber, Penadés et al. 2017).
Conjugation is the process by which one bacterium transfers genetic material to another
through direct cell-to-cell contact. Conjugative plasmids carry a DNA sequence called the
fertility factor, or F-factor that allows for pore formation for the transfer of DNA through the
pore to the recipient cell (Ramsay, Kwong et al. 2016). The relaxase (Nes) is also encoded in the
plasmid, and it recognizes and cleaves the plasmid DNA at the origin of transfer (oriT) (Yin and
Stotzky 1997, Haaber, Penadés et al. 2017). tra genes on the plasmid produce the proteins
necessary for a type IV secretion system. A coupling protein then binds to the plasmid DNA,
adding in the transfer of the DNA through the pore via the type IV secretion system. In the
recipient cell, the plasmid can either replicate further or integrate into the recipient cell
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chromosome (Yin and Stotzky 1997, Ramsay, Kwong et al. 2016, Haaber, Penadés et al. 2017).
Only about 5% of S. aureus plasmids encode all the products that are required for autonomous
transfer (Ramsay, Kwong et al. 2016). However, conjugative plasmids can carry an extensive
and variable range of antibiotic and heavy metal resistance genes and are an important source of
the transfer of resistance genes, particularly of resistance to MLS antibiotics (McCarthy, Loeffler
et al. 2014, Liu, Chen et al. 2016).
Transformation is the uptake of foreign DNA by bacteria. It was traditionally believed that
natural transformation does not occur in S. aureus, however, recent studies have shown situations
and environments where natural transformation does occur (Morikawa, Takemura et al. 2012,
Thi, Romero et al. 2016, Maree, Nguyen et al. 2020, Cordero, García-Fernández et al. 2022,
Feng, Hauck et al. 2022). Natural transformation requires a series of competence factors,
encoded in the comG operon (Morgene, Zeghlache et al. 2022). Expression of competence genes
in S. aureus is regulated by an alternative sigma factor, SigH. A study done by Morikawa et al.
found that high levels of SigH, either through a gene duplication or derepression of posttranscriptional regulation, allows natural transformation of S. aureus cells of both chromosomal
and plasmid DNA (Morikawa, Takemura et al. 2012). Another study found that cell-wall-acting
antibiotics can also modulate SigH expression and can increase transformation efficiency (Thi,
Romero et al. 2016, Maree, Nguyen et al. 2020). Environmental factors such as biofilm
environments and low oxygen environments have also been shown to increase transformation
efficiency (Maree, Nguyen et al. 2020, Feng, Hauck et al. 2022). The results from these recent
experiments suggest that transformation is likely a bigger player in the transfer of antibiotic
resistance genes in S. aureus than previously thought. Multiple studies have shown SCCmec
transfer via natural transformation from MRSA to MSSA, suggesting transformation as an
9

important mechanism for the transfer of methicillin resistance in S. aureus (Morikawa, Takemura
et al. 2012, Thi, Romero et al. 2016, Maree, Nguyen et al. 2020). Investigating transformation of
S. aureus in different environments, such as in biofilms and under in vivo conditions, can help to
identify factors that increase transformation efficiency and possible sources for the spread of
antibiotic resistance in S. aureus.
Staphylococcus aureus Biofilms
The formation of biofilms plays an important role in the persistence of chronic S. aureus
infections (Moormeier and Bayles 2017, Parastan 2020). Biofilms are communities of cells that
are encased in an extracellular matrix (ECM) composed of polysaccharides, proteins, and DNA.
The ECM helps to protect cells from immune defenses, antibiotics, and other antimicrobials,
making biofilm infections particularly difficult to treat (Archer, Mazaitis et al. 2011, Lister 2014,
Parastan 2020).
Biofilm development occurs in 3 stages: attachment, maturation, and dispersal. During
the attachment stage, planktonic cells adhere to a surface and proliferate into microcolonies
(Lister 2014). A subpopulation of cells autolyze, releasing eDNA needed for attachment and
maturation of the biofilm (Thomas and Hancock 2009). Autolysis is mediated by murein
hydrolases, encoded by atl and lytM. Murein hydrolases that degrade peptidoglycan in the cell
wall, ultimately causing cell lysis (Mann, Rice et al. 2009, Thomas and Hancock 2009).
Autolysis is regulated by the cidABC and lrgAB operons (Ranjit, Endres et al. 2011). These
operons function similar to bacteriophage holin and antiholin systems respectively (Rice, Mann
et al. 2007, Ranjit, Endres et al. 2011). CidA acts as a holin and forms a pore that allows the
murein hydrolase (atl/lytM) access to the peptidoglycan (Rice, Mann et al. 2007, Ranjit, Endres
et al. 2011, Endres, Chaudhari et al. 2022). LrgAB acts as an antiholin and inhibits the activity of
10

CidA (Rice, Mann et al. 2007, Ranjit, Endres et al. 2011). Studies found that mutations in the cid
and lrg operons decreased and increased biofilm formation, respectively (Rice, Mann et al. 2007,
Ranjit, Endres et al. 2011). Regulation of autolysis is tied to micro-environmental niches that
form within a biofilm, allowing for DNA release from a subpopulation of cells in the beginning
stages of biofilm development that is necessary for biofilm attachment and stability (Ranjit,
Endres et al. 2011).
As the microcolonies formed during attachment develop and grow, the cells produce an
ECM that acts to protect the cells and serves as a scaffold for establishing the biofilm’s structure
(Lister 2014). Once the microcolonies reach sufficient cell density, the Agr system regulates
gene expression through quorum sensing (Yarwood 2004). Quorum sensing is population
density-dependent and environment-dependent gene regulation that occurs through cell-to-cell
communication (Waters and Bassler 2005). Quorum sensing allows for differential gene
expression within a biofilm and at different stages throughout biofilm development (Yarwood
2004, Waters and Bassler 2005). Cells near the surface of the biofilm are metabolically active
while cells located towards the base of the biofilm get switched to an inactive state (Yarwood
2004). Later in biofilm maturation, metabolically dormant cells are found near the base of the
biofilm called persister cells (Conlon 2014). These cells are protected by the thick layer of ECM
shielding them and display high levels of tolerance to a variety of antibiotics (Keren, Kaldalu et
al. 2004, Conlon 2014). This allows persister cells to survive amidst antibiotic treatment and then
switch to an active state to regrow the biofilm (Keren, Kaldalu et al. 2004, Conlon 2014).
Dispersal occurs once a specific cell density is reached which triggers to initiate ECM
degradation (Lister 2014). Cells embedded within the biofilm are then released to disperse and
can result in biofilm formation at secondary sites and worsening of an infection (Lister 2014).
11

Traditionally, MRSA and MSSA were thought to have different biofilm compositions
with MSSA forming polysaccharide intercellular adhesin (PIA) dependent biofilms and MRSA
having PIA-independent, protein and DNA based, biofilms (Figure 1) (Lister 2014). PIA is
produced and exported by enzymes encoded in the icaADBC locus (Lister 2014, Arciola,
Campoccia et al. 2015). The PIA polymer plays an important role in the structural integrity of
biofilms, although some S. aureus strains are capable of forming ica-independent biofilms
(Fitzpatrick F 2005, Lister 2014, Arciola, Campoccia et al. 2015). In the absence of PIA, proteins
and eDNA function as intercellular adhesins (Fitzpatrick F 2005). More recent studies suggest
that the model described in Figure 1 is too simplistic and that MRSA and MSSA strains contain
proteins, polysaccharides, and eDNA as important components in biofilm structure and strains
can spontaneously switch from PIA-dependent to PIA- independent (Hennig S 2007, Houston
2011, Lister 2014).
Biofilms, along with protecting cells from immune defenses and antibiotics, also provide
an environment that serves as a hot spot for horizontal gene transfer (Molin and Tolker-Nielsen
2003, Madsen, Burmølle et al. 2012, Abe, Nomura et al. 2020). This increases the risk for the
spread of antibiotic resistance in biofilms, potentially making these already difficult to treat
infections, even more dangerous. A better understanding of the development and composition of
Staphylococcal biofilms is imperative to generate new treatment strategies for biofilm-associated
infections and to reduce the significant burdens caused by this pathogen.
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Figure 1. Previous Model of MRSA and MSSA Biofilms. MSSA biofilm composition was proposed by
Archer et al. to be PIA-dependent (left hand side of A and B), and MRSA biofilm composition proposed to
be PIA-independent and composed of eDNA and surface proteins (right hand side of A and B) (Archer,
Mazaitis et al. 2011)
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CHAPTER II: Characterization of Staphylococcus aureus Biofilms via Crystal Violet Binding
and Biochemical Composition Assays of Isolates From Hospitals, Raw Meat, and BiofilmAssociated Gene Mutants

Introduction
Staphylococcus aureus (SA) is a major cause of nosocomial and community-acquired
infections, making it a significant threat to public health. SA infections have become
increasingly serious, with some forms of SA causing mortality rates as high as 30–67% despite
treatment (Tong 2015). One of the factors that makes SA infections so problematic is the
production of biofilms (Periasamy, Joo et al. 2012). Biofilms are communities of bacteria that
can produce a robust extracellular matrix, protecting the cells from host immune responses,
antibiotics, and other antimicrobials (Lister 2014). In biofilm attachment and maturation,
planktonic bacteria attach themselves to a surface and build an extracellular polymeric matrix
that can be composed of extracellular DNA (eDNA), protein, and polysaccharides. This
polymeric shield often creates a strong antibiotic resistance, making biofilm dispersal critical to
both treatment and prevention of infection(Gebreyohannes 2019).
SA biofilms vary in composition across different strains. Methicillin-susceptible SA
(MSSA) has been reported to require polysaccharide intercellular adhesin (PIA) to be able to
produce a biofilm while methicillin-resistant SA (MRSA) does not (McCarthy 2015).
Polysaccharides are the main component of MSSA biofilms while MRSA biofilms are believed
to be predominantly composed of proteins and eDNA (McCarthy 2015). This, however, is a
simplified model of biofilm composition in SA, and here we study biofilm composition in 36
MRSA and 18 MSSA strains to investigate whether variability exists between MRSA and MSSA
strains, and between hospital and meat-associated isolates. Hospital-associated SA isolates
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obviously have important clinical relevance to human infections, although meat SA isolates only
rarely cause disease in humans(Carrel, Zhao et al. 2017). However, we and others have reported
that meat SA isolates have high levels of antibiotic resistance, likely due to high antibiotic usage
in livestock(Landers, Cohen et al. 2012, Wu, Huang et al. 2018). Biofilms of many bacterial
species are known to be hotspots of horizontal gene transfer, and thus we are interested in the
biofilm-forming capacity and composition of meat SA as well. In order to break down existing
biofilms or to prevent their development, it is important to understand their composition and
which genes/proteins are involved in the formation of biofilms(Brady, O'May et al. 2011). There
is still only a basic understanding of SA biofilm structure and growth mechanisms, and a better
elucidation of these areas through studying the genes involved in biofilm formation, as well as
how biofilm composition varies between strains, will be critical for further therapeutic
developments(Gebreyohannes 2019).
This study investigates specific genes that may be involved in biofilm formation found
through previous genetic screenings of SA (Table 1). Most of the studied genes were found to be
upregulated during biofilm development, and therefore, are likely associated with biofilm
formation(Beenken 2004). These genes were knocked out in the MRSA strain JE2 using
transposons(Bose, Fey et al. 2013), and the effects on biofilm composition were assessed using a
crystal violet biofilm assay. As several therapeutic options for treating mature SA biofilms
require a more complete understanding of biofilm composition, a better understanding of how
genes influence composition is critical to improving current treatments and developing new
ones(Bhattacharya 2015). While the roles of many of these genes have been studied, little
research has been done on how these genes impact the macromolecules of biofilms that form
when these genes are lacking(Kot 2018).
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In this study, we investigated the biofilm composition of different strains of both
livestock- and hospital-associated SA, including both MRSA and MSSA, and the effect that
mutating biofilm-associated genes has on MRSA biofilm composition. We believe that by
identifying the impact of various genes on biofilm makeup, we can increase the understanding of
the specific roles of these genes in biofilm formation and identify potential genes to target
therapeutically.
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Table 1. Biofilm-Associated Genes and Their Reported Functions.
Gene

Protein function

fnbA/fnbB

Binds fibronectin, a glycoprotein of the extracellular matrix. A knock-out in these genes
has resulted in total abolishment of biofilm formation under some conditions
(Fitzpatrick F 2005).

clfA/clfB

Binds fibrinogen, an extracellular precursor to fibrin, which creates rigid fibrous
meshwork, promotes cell-to-cell adhesion (Foster 2014).

ebpS

An integral membrane protein that binds elastin, a component of the extracellular
matrix that provides elasticity and resiliency (Kot 2018).

purH

An enzyme catalyzing the last step in purine synthesis in the pentose phosphate
pathway (Beenken 2004). Purine synthesis contributes to biofilm growth and virulence
factor regulation (Sause 2019).

coa

Binds fibrinogen and mediates the conversion of fibrinogen into fibrin which is then
recruited into the extracellular matrix for biofilm formation (Zapotoczna 2016).

sarA

DNA binding protein. Positive regulator of virulence genes, including some that are
essential for biofilm production (Bap, icaABCD, etc.) (Trotonda 2005).

icaA/icaB/icaC Synthesizes a transmembrane protein present in polysaccharide biofilms (Arciola,
Campoccia et al. 2015).
agrA

Response regulator in the agr quorum sensing system. Activates several promoters
related to virulence factors (Rajasree 2016).

acnA

Catalyst of the TCA cycle (De Backer 2018). Downregulated in small-colony variants
of Staph aureus, which have increased biofilm production and are associated with
chronic infection (Kriegeskorte 2014).

atl

Major autolysin protein. Essential for cell attachment and biofilm formation in MRSA
strains (Houston 2011).

lacA/lacB

Essential for the transport and metabolism of lactose. No known role in biofilm
development (van Rooijen 1991).

malABC

Maltose transporter. No known role in biofilm development (Noll 2008).
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Materials and Methods
Characterization of SA Strains
Thirty-two meat SA strains (21 MRSAs and 11 MSSAs) were collected from samples of
retail meat products (from a variety of meat types including beef, pork, chicken, and turkey)
purchased from 11 different retailers in Utah. Twenty-two hospital SA strains (15 MRSAs and 7
MSSAs) were acquired through culture collections and a hospital pathology department. Meat
and hospital-associated isolates were confirmed as SA via growth and fermentation on mannitol
salt agar (MSA), gram staining, and catalase and coagulase testing(Kateete 2010, Chan 2013,
Haskell, Schriever et al. 2018). Isolates were further confirmed as SA through PCR amplification
of the SA 16S rRNA and nucA genes(Maes 2002, Haskell, Schriever et al. 2018). Additionally,
these strains were identified as MRSA or MSSA through their ability to grow in selective media
containing 2 μg/mL of oxacillin and through PCR amplification of the mecA gene(Maes 2002,
Haskell, Schriever et al. 2018). Clonal complexes for 10 hospital-associated SA strains were
found from a previous study by Suzuki et al.(Suzuki, Matsumoto et al. 2009). Clonal complexes
for 5 meat-associated SA strains were determined by extracting the DNA using the Omega BioTek DNA extraction kit and then performing whole genome sequencing for those strains.
Samples were sent to the Microbial Genome Sequencing Center (MiGS) to be sequenced via
Illumina sequencing. Raw sequencing reads were then run through a program on the Center for
Genomic Epidemiology site to determine their clonal complexes.
Crystal Violet Biofilm Staining Assay
Strains to be tested were grown overnight without shaking at 37 °C in tryptic soy broth
(TSB) (Sigma-Aldrich, St. Louis, MO). Cultures were then diluted 1:200 in 66% TSB with 0.5%
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glucose. 200 μL of diluted culture was then added to wells of a 96-well, flat-bottomed, tissue
culture-treated plate (Corning Incorporated, Corning, NY). After overnight growth, the liquid
and non-adhered cells were then removed from the wells by gently overturning the plate onto
paper towels. Each well was then gently washed with phosphate-buffered saline (PBS) three
times and allowed to dry. 205 μL of 100% ethanol was added to each well to fix biofilms and left
to dry. Once the ethanol had dried 205 μL of 0.1% crystal violet (CV) dye diluted in ddH2O was
added to each well and incubated for 15 minutes at room temperature. The dye was then emptied
as before, by overturning the plate onto paper towels, and three washes with 210 μL of ddH2O
were performed. The plates were left to dry overnight, and then the stain was eluted using 205
μL of elution buffer (ddH2O with 40 mM HCl and ⅓ volume ethanol added). 80 μL of eluted
CV was removed from each well and placed into wells of a new 96-well plate for measuring the
optical density (OD) at 595 nm in a Victor Nivo Plate Reader, providing a quantitative measure
of biofilm mass. All tests were run in quadruplicate and re-run three separate times to confirm
reproducibility. P-values comparing biofilm masses between strains were determined by
performing two-sample T-tests assuming equal variances.
Proteinase K and DNase Treatment
Biofilm composition assays were performed using a similar method to that described for
the general biofilm assay with an added enzymatic treatment step after the biofilms are first
drained and washed with PBS, but before ethanol fixation. After biofilms had been grown for 24
hours in a 96-well tissue culture-treated plate, planktonic cells were gently washed from the
wells and a solution of proteinase K (100 μg/mL proteinase K in 10 mM Tris-HCl, pH 7.5;
Millipore Sigma), DNase (140 μg/mL DNase in TSB; Millipore Sigma), or a mock treatment,
was added to each well. The mock treatment consisted of the same buffer as used for enzyme
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treatment, but without the enzyme. After incubation at 37 °C for 2 hours the wells were gently
washed, and the biofilms were fixed and stained as above. The stain was then eluted, and OD
was measured at 595 nm as above. The mean OD reading of the enzymatically treated biofilms
was then subtracted from that of the mock-treated biofilms, and the ‘percent reduction’ was then
calculated by taking the difference divided by the mock-treated value to normalize the data. This
allowed a simpler comparison between robust biofilm-forming strains (e.g., bind a lot of CV)
and weak biofilm-forming strains. P-values were determined by performing two-sample T-tests
assuming equal variances.
Extracellular Matrix (ECM) Extraction
Isolates were grown up overnight in shaking cultures (200 rpm) in 3 mL of TSB at 37 °C.
Overnight cultures were diluted 1:200 in 66% TSB +0.5% glucose. Diluted cultures were
transferred to 96 well plates using three wells per isolate (200 μL per well). Biofilms were grown
up for 24 hours in 37 °C without shaking. After 24 hours, wells were dumped and washed with
dH2O. Biofilms were scraped and resuspended in 50 μL of 1X PBS. The entire contents of the
well were then transferred to microcentrifuge tubes. The microcentrifuge tubes were centrifuged
at 8000 g for 10 minutes and the supernatant was removed. The pellet was resuspended in 1.5 M
NaCl and centrifuged at 5000 g for 10min. The supernatant was transferred to a new
microcentrifuge tube for subsequent testing of ECM components.
Measuring Protein, Polysaccharide, and DNA Concentrations from Extracted ECM
Extracted ECMs were tested for biofilm protein concentration using the Bradford assay
as described by Chiba et al.(Chiba, Sugimoto et al. 2015). Polysaccharide concentration was
tested using the phenol-sulfuric acid assay as described by Lakshmi et al.(Lakshmi, Bhaskar et
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al. 2020). Polysaccharide concentrations for each isolate were normalized by dividing by the
corresponding OD595 value reported in Figure 2; this was necessary because baseline biofilms
varied widely amongst the isolates tested. DNA concentrations were measured by purifying the
DNA from the extracted ECM using the Omega Bio-Tek DNA extraction kit and measuring
purified DNA concentration in a NanoDrop 2000. Protein and DNA concentrations were tested
for 8 isolates to analyze the correlation between these results and crystal violet binding reduction
when treated with either proteinase K or DNase. These 8 isolates (each run in triplicate)
represent a random spread of low, medium, and high biofilm reduction with proteinase K and
DNase A for MSSA, MRSA, hospital-associated, and meat-associated isolates. The results were
analyzed by plotting out the absolute change in OD595 units in mock-treated vs DNase or
proteinase K-treated biofilms as compared to concentrations of DNA or protein extracted from
biofilms. An F-test of Overall Significance was performed on the R2 values to determine the
significance of the correlation. All isolates were tested (and run in triplicate) for polysaccharide
concentration, and p-values were determined by performing two-sample T-tests assuming equal
variances.
Transposon Mutants
Biofilm-associated gene mutants were chosen based on gene function and previous
studies suggesting these genes to play important roles in biofilm formation (see Table 1). All
transposon mutants were obtained from the University of Nebraska transposon (Tn) mutant
library. These mutants were generated in the backbone of strain JE2, which was derived from
USA300 strain LAC, a highly characterized community-associated MRSA strain isolated from
the Los Angeles County jail(Bose, Fey et al. 2013). Strain LAC contains three plasmids
encoding resistance to tetracycline, erythromycin, and the third plasmid is cryptic(Bose, Fey et
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al. 2013). All three plasmids were cured, yielding the JE2 strain that was used for all Tn
mutagenesis experiments to create the transposon mutants(Bose, Fey et al. 2013). All transposon
mutants were created by Tn insertion of the mariner Tn bursa aurealis in each mutated
gene(Bose, Fey et al. 2013). Tn insertion sites were analyzed to ensure the mutation was likely to
completely deactivate the gene, which may be less likely to occur if inserted into the 3’ end of
the gene (see Supplementary Table 1).
Analysis of sdr Gene Prevalence in SA Isolates
Genomic and plasmid DNA for five bacterial isolates was extracted using E.Z.N.A
Bacterial DNA Kit (Omega Bio-Tek). Illumina DNA libraries were prepared at the Microbial
Genome Sequencing Center (Pittsburgh, PA, USA) and sequenced on the NextSeq2000
(Illumina) platform. Sequence data were returned as FASTQ files containing paired-end 150 bp
reads. A de novo genome assembly was conducted with the open-source SPAdes
algorithm(Prjibelski, Antipov et al. 2020).

A custom BLAST + database was generated from the FASTA sequence files that
contained the assembled contigs from each genome(Camacho, Coulouris et al. 2009). This
software enables the alignment of query sequences against assembled genomes or contigs to
identify homologous sequences. Query files consisted of whole-gene nucleotide sequences for
sdrC, sdrD, and sdrE from SA strain Newman (GenBank accession numbers AJ005645.1,
AJ005646.1, and AJ005647.1 respectively). Homology hits were returned as tab-delimited files
containing sequence identity percentages, e-values, and other metrics. A bacterial isolate was
considered positive for any of the selected sdr genes if its sequence identity was greater than
75% and e-value was less than 1x10E-50.
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Results
Characterization of Biofilm Mass from Hospital vs Meat-Associated Isolates
Thirty-two SA isolates (11 MSSA and 21 MRSA) were collected from beef, pork,
chicken, and turkey samples of retail meat products, as previously reported(Haskell, Schriever et
al. 2018). A description of these strains, their origins, and their oxacillin resistance is shown in
Table 2. Additionally, we acquired 22 SA strains (15 MRSA and 7 MSSA) through culture
collections and a hospital pathology department (Table 2). Antibiotic resistance patterns for the
32 meat isolates has previously been reported(Haskell, Schriever et al. 2018). Antibiotic
resistance for the culture collection isolates can largely be found at atcc.org. The clonal complex
of some culture collection isolates was found online and is reported in Table 2. We extracted and
sequenced the DNA from some meat isolates and identified their clonal complexes. Clonal
complex information, when known, is indicated in Table 2.
Overall biofilm mass formed by hospital-associated and meat-associated isolates was first
tested by measuring CV staining of biofilms formed after overnight growth. We found the
biofilm mass to vary considerably from strain to strain in both meat-associated and hospitalassociated isolates (Figure 2A and B). The mean OD595 for meat-associated isolates (1.02 ±
0.042), however, was significantly lower than the mean OD595 for hospital-associated isolates
(1.29 ± 0.075), (Figure 2C), indicating that the hospital-associated isolates formed significantly
more robust biofilms (p = 7.0x10−3).
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We conducted a similar analysis of biofilm mass of all 36 MRSA and 22 MSSA isolates
mentioned above, irrespective of origin. We found that MRSA biofilms (1.02 ± 0.038) bound
significantly more CV (p = 0.02) than MSSA biofilms (0.91, ±0.44) (Figure 2D).

Biochemical Characterization of Hospital vs Meat-Associated Isolates
We then tested the biofilms formed by each strain for susceptibility to degradation by
proteinase K or DNase to determine protein and eDNA composition of the biofilms, respectively.
We also measured polysaccharide concentrations in the biofilms using the phenol sulfuric-acid
assay on isolated ECMs from the biofilms.
Both hospital-associated and meat-associated SA groups had some isolates where
biofilms were highly affected by proteinase K treatment (such as P5 or HA2) and some strains
which were largely unaffected (such as C9 or SA 25923) (Figure 3A and B). We observed a
significant difference in proteinase K susceptibility between hospital-associated and meatassociated isolates. When treated with proteinase K, the average reduction of meat-associated
biofilms (33.2 ± 4.6%) was significantly lower than that of hospital-associated isolates (52.0 ±
6.3%) (p = 8.1x10−4), suggesting that hospital-associated isolates have a greater concentration of
proteins in their biofilms as compared to meat-associated isolates (Figure 3C). Protein
concentrations from extracted ECMs were tested on a sample of 8 meat and hospital isolates
using the Bradford assay. There was a significant positive correlation between protein
concentration and absolute crystal violet binding reduction with proteinase K treatment (R2 =
0.904, Significance F < 0.01) (see Supplementary Figure 1).
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Table 2. List of Meat-Associated and Hospital-Associated S. aureus Strains. Meat-associated
strains are shown on the left, hospital-associated strains are shown on the right. A total of 32
meat-associated strains were studied (21 MRSA, 11 MSSA) and a tot al of 22 hospital-associated
strains were studied (15 MRSA, 7 MSSA).
Strain
name

Type

Source

Clonal
Complex

Strain name

Type

Source

Clonal
Complex

C1

MRSA Raw
chicken

97

T10

MRSA Raw turkey

N/A

C2

MRSA Raw
chicken

97

T12

MSSA Raw turkey

N/A

C3

MRSA Raw
chicken

N/A

T13

MSSA Raw turkey

1

C7

MRSA Raw
chicken

N/A

T14

MRSA Raw turkey

N/A

C11

MRSA Raw
chicken

N/A

B8

MRSA Raw beef

N/A

C15

MRSA Raw
chicken

N/A

HA 1

MRSA Hospital
pathology lab

N/A

C20

MRSA Raw
chicken

N/A

HA 2

MRSA Hospital
pathology lab

N/A

C4

MSSA Raw
chicken

N/A

HA 3

MRSA Hospital
pathology lab

N/A

C6

MSSA Raw
chicken

N/A

HA 4

MRSA Hospital
pathology lab

N/A

C9

MSSA Raw
chicken

N/A

HA 5

MRSA Hospital
pathology lab

N/A

C10

MSSA Raw
chicken

N/A

FR1913

MRSA Culture
collection

N/A

P3

MRSA Raw pork N/A

USA 300
LAC (JE2)

MRSA Culture
collection

8

P4

MRSA Raw pork N/A

HFH 30364

MRSA Culture
collection

1

P5

MRSA Raw pork N/A

NY336

MRSA Culture
collection

N/A

25

Strain
name

Type

Source

Clonal
Complex

Strain name

Type

Source

Clonal
Complex

P6

MRSA Raw pork N/A

CO34

MRSA Culture
collection

N/A

P11

MRSA Raw pork N/A

GA92

MRSA Culture
collection

N/A

P14

MRSA Raw pork N/A

TN112

MRSA Culture
collection

N/A

P7

MSSA Raw pork N/A

CA127

MRSA Culture
collection

N/A

P9

MSSA Raw pork N/A

USA 400

MRSA Culture
collection

1

P10

MSSA Raw pork 8

USA 3000114

MRSA Culture
collection

8

P12

MSSA Raw pork 1

SH 1000

MSSA Culture
collection

45

P13

MSSA Raw pork N/A

SA 6538

MSSA Culture
collection

97

T2

MRSA Raw
turkey

N/A

SA 29213

MSSA Culture
collection

5

T4

MRSA Raw
turkey

N/A

SA 25923

MSSA Culture
collection

30

T5

MRSA Raw
turkey

N/A

SA 43300

MSSA Culture
collection

1

T6

MRSA Raw
turkey

N/A

SA 4651

MSSA Culture
collection

N/A

T7

MRSA Raw
turkey

N/A

SA 12600

MSSA Culture
collection

8
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Figure 2. Baseline Biofilm Mass Measured by Crystal Violet Binding Assay for MeatAssociated and Hospital-Associated S. aureus Strains: (A) Varying OD at 595 nm of 32 meatassociated SA strains. (B) Varying OD of 22 hospital-associated SA strains. (C) Average bi
ofilm mass of hospital-associated SA strains and meat-associated SA strains (p < 0.05). (D)
Average biofilm mass of all MRSA and all MSSA isolates (p = 0.024). MSSA shown in light
gray and MRSA in dark gray.
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Figure 3. Biofilm Mass After Proteinase K Treatment for Hospital-Associated and MeatAssociated S. aureus Strains: (A&B) percent reduction of biofilm varies between meatassociated SA strains (A) and hospital-associated strains (B) when treated with proteinase K
(MSSA in light gray and MRSA in dark gray). (C) The average percent reduction of biofilm of
meat strains and hospital strains when treated with proteinase K (p < 0.001). (D) Average percent
reduction of biofilm when treated with proteinase K for all MRSA and MSSA isolates (p = 0.08).
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We performed a similar analysis of the protein content of all MRSA vs MSSA strain
biofilms. We failed to find a significant difference in proteinase K susceptibility between
biofilms formed by MRSA (44.2 ± 3.4%) and MSSA (34.6 ± 5.8%) (p = 0.08; Figure 3D).

Like proteinase K, when treated with DNase, both meat and hospital-associated isolates
showed varying degrees of biofilm reduction (Figure 4A and B). When treated with DNase, the
average reduction of biofilms for meat-associated isolates (47.9 ± 4.3%) was significantly higher
than for hospital-associated isolates (39.4 ± 5.2%) (p = 3.4x10−3), suggesting that meatassociated isolates on average have more eDNA in their biofilms (Figure 4C). As before, we
analyzed our data for differences in susceptibility to DNase treatment in all MRSA vs all MSSA
isolates. We did not detect a significant difference between DNase susceptibility in MRSA (42.5
± 2.9%) vs MSSA isolates (44.5 ± 3.5%) (p = 0.33; Figure 4D).
DNA concentrations from extracted ECMs were tested on a sample of 8 meat and
hospital isolates. There was a significant positive correlation between DNA concentration and
crystal violet binding reduction with DNase treatment (R2 = 0.895, Significance F < 0.01) (see
Supplementary Figure 2).
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Figure 4. Biofilm Mass After DNase Treatment for Hospital-Associated and MeatAssociated S. aureus Strains: (A&B) percent reduction of biofilm varies between meatassociated SA strains (A) and hospital-associated strains (B) when treated with DNase (MSSA in
light gray and MRSA in dark gray). (C) The average percent reduction of meat and hospitalassociated strains when treated with DNase (p < 0.05). (D) Average biofilm mass of all MRSA
and all MSSA isolates (p = 0.33).
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Meat and hospital-associated isolates also showed varying polysaccharide concentrations
in their biofilms (Figure 5A and B). We observed no significant difference between
polysaccharide concentrations when normalized to base biofilm strength for hospital-associated
(31.9 ± 2.9 μM/OD595) and meat-associated (32.0 ± 2.6 μM/OD595) isolates (Figure 5C).
However, the average polysaccharide concentration of MSSA biofilms normalized to the base
biofilm strength (36.5 ± 4.2 μM/OD595) was significantly higher than that of MRSA biofilms
(29.7 ± 1.8 μM/OD595, p = 0.03) (Figure 5D), suggesting that MSSA biofilms have higher
amounts of polysaccharides in their biofilms than MRSA biofilms.
Characterization of Biofilm Mass of Transposon Mutants in MRSA Background
SA strains with mutations in biofilm-associated genes discovered in previous studies
were also tested for biofilm formation and composition. First, an array of SA mutants in the JE2
strain was acquired from the University of Nebraska transposon mutant library. acnA, agrA, atl,
clfA, clfB, coa, ebpS, fnbA, fnbB, icaA, icaB, icaC, purH, and sarA mutants were tested with
lacA, lacB, and malABC mutants used as controls as they are not thought to contribute to biofilm
formation (Figure 6). A summary of each of these genes, and the proposed role in biofilm
formation, is provided in Table 1. The clfB, coa, ebpS, fnbB, icaB, icaC, lacA, lacB, and malABC
mutants showed no significant difference from the wild-type JE2 strain in overall biofilm
formation (no enzymatic treatment). However, the clfA (8.9% ±1.3, p = 0.04), fnbA (9.1% ±1.6, p
= 0.03), purH (18.7% ±1.7, p = 0.003), sarA (42.2% ±9.9, p = 0.005), and atl (29.9% ±9.1, p =
0.02) mutants all showed significant reductions in biofilm formation when compared to WT
(JE2), and the acnA (17.6% ±10.2, p = 0.04) and agrA (9.8% ±8.8, p = 0.05) mutants showed a
significant increase in biofilm formation.
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Figure 5. Polysaccharide Concentrations for Hospital-Associated and Meat-Associated S.
aureus Strains: (A&B) Polysaccharide concentrations determined by the phenol sulfuric-acid
assay shows varying amounts of polysaccharide in meat-associated SA strains (A) and hospitalassociated strains (B) (MSSA in light tan and MRSA in black). (C) The average polysaccharide
concentration of meat and hospital-associated strains (p = 0.5). (D) Average polysaccharide
concentration of all MRSA and MSSA isolates (p = 0.03).
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Figure 6. Baseline Biofilm Mass of Biofilm-Associated Transposon Mutants. S. aureus (JE2)
strains were grown in biofilms in 96 well plates and stained using crystal violet to determine
biofilm mass. N = 4 for each isolate; and the entire experiment was run in triplicate with one
representative experiment shown here depicting the mean untreated, normal biofilm growth of
the 17 strains, each containing a specific gene knockout, compared to the normal growth of the
wild-type (WT), JE2. Asterisks indicate a significant difference in biofilm mass from the WT
with clfA, fnbA, sarA, purH and atl showing a significant decrease in CV binding (p < 0.05)
and agrA and acnA showing a significant increase in CV binding (p < 0.05).
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Biochemical Characterization of JE2 Mutant Biofilms
The mutant strains that showed a significant difference in biofilm formation when
compared to WT JE2 (acnA, agrA, atl, clfA, fnbA, purH, and sarA) were further tested to
understand the effects of these mutations on biofilm composition. Biofilms from these strains
were treated with proteinase K as above (Figure 7). The WT strain, JE2, had a 36.2 ± 3.1%
biofilm reduction upon proteinase K treatment. After proteinase K treatment, the OD595 of JE2
was significantly lower than mock treatment (p = 0.003). Proteinase K treatment of biofilms
generated with the following mutants also showed significant differences as compared to mock
treatments of the same strain: acnA (28.7 ± 9.9% reduction, p = 0.05), agrA (73.8 ± 1.3%
reduction, p = 0.001), clfA (54.2 ± 1.6% reduction, p = 0.001), fnbA (43.0 ± 1.7% reduction, p =
0.004), purH (56.9 ± 2.7% reduction, p = 0.001), and sarA (35.4 ± 5.7% reduction, p = 0.007). In
contrast, we found that atl showed a significant increase in biofilm staining after proteinase K
treatment (12.7 ± 1.6% increase, p = 0.005).
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Figure 7. Biofilm Mass of Biofilm-Associated Transposon Mutants Treated with Proteinase
K. Mutant MRSA strains were grown in biofilms and either treated with Proteinase K or mocktreated as a control. The average OD for each strain was divided by the average OD for the mock
treatment of each strain to normalize for OD differences between experiments. Asterisks indicate
proteinase K-treated biofilms that were significantly reduced from the mock-treated biofilms.
(p < 0.05). (M = mock treated, PK = proteinase K treated).
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To explore the role that eDNA plays in biofilm formation in the mutant strains previously
tested (acnA, agrA, atl, clfA, fnbA, purH, and sarA), these strains were grown in biofilms and
treated with DNase as above (Figure 8). The WT had a 19.2 ± 7.7% biofilm reduction upon
DNase treatment, and the OD595 of the WT with DNase treatment was significantly lower than
the OD595 of the WT with the mock treatment (p = 0.002). acnA (37.7 ± 6.7% reduction, p =
0.001), clfA (34.2 ± 8.1% reduction, 0.002), purH (47.8 ± 5.9% reduction, p = 0.006), and fnbA
(38.7 ± 5.2% reduction, p = 0.002) also showed significant biofilm reduction when treated with
DNase, suggesting that eDNA still plays an important role in the structure of the biofilms despite
the mutation. agrA, atl, and sarA did not show any significant differences in biofilm staining
when treated with DNase, displaying 9.9 ± 3.3% (p = 0.16), 21.6 ± 14.7% (p = 0.19), and 6.8 ±
2.1% (p = 0.42) biofilm reduction upon DNase treatment, respectively.

The phenol-sulfuric acid assay was performed on the mutant strains (acnA, agrA, atl,
clfA, fnbA, icaA, icaB, icaC, malABC, purH, and sarA) to measure polysaccharide concentrations
in each of their biofilms (Figure 9). Polysaccharide concentrations were normalized to the base
biofilm OD595. atl (58.8 ± 1.3 μM/OD595, p < 0.05) and sarA (65.6 ± 2.4 μM/OD595, p < 0.05)
mutants had significantly higher biofilm polysaccharide concentrations than the WT, suggesting
that polysaccharides play an important role in the structure of these mutant biofilms. acnA (23.1
± 0.95 μM/OD595, p = 0.03), clfA (21.7 ± 1.3 μM/OD595, p = 0.03), and fnbA (22.8 ± 2.9
μM/OD595, p = 0.04) had significantly lower biofilm polysaccharide concentrations than the
WT, suggesting that these biofilms rely more on proteins and DNA for their biofilm structure.
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Figure 8. Biofilm Mass of Biofilm-Associated Transposon Mutants Treated with DNase.
Mutant MRSA strains were grown in biofilms and either treated with DNase or mock treated
as a control. The average OD for each strain was divided by the average OD for the mock
treatment of each strain to normalize for OD differences between experiments. Asterisks
indicate DNase treated biofilms that were significantly reduced from the mock treated
biofilms. (p < 0.05). (M = mock treated, D = DNase treated).
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Figure 9. Polysaccharide Concentration for Transposon Mutants. Polysaccharide
concentrations determined by the phenol sulfuric-acid assay on isolated ECM for JE2
transposon mutants. Asterisks indicate a significant difference in polysaccharide
concentration from the wild type. atl and sarA mutants both had significantly higher
polysaccharide concentrations from the wild type (p < 0.05, p < 0.05). acnA, clfA,
and fnbA mutants had significantly lower polysaccharide concentrations from the wild type
(p = 0.03, p = 0.03, p = 0.04).
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sdr Gene Prevalence in S. aureus Isolates
We next wanted to determine whether the sdr gene locus, which encodes cell surface
adhesin proteins, played a role in SA biofilm development. We performed whole genome
sequencing on two MRSA strains (USA400 and C2) and three MSSA strains (P10, P12, T13) for
subsequent genomic analysis. Our bioinformatics approach used representative reference
sequences for each of the three sdr genes as queries against a custom database containing the de
novo assembled contigs from each genome. The BLAST results revealed that all five isolates
contained both the sdrC and the sdrD genes, but only three (USA400, P10, P12) contained the
sdrE gene (See Supplementary Table 2). The variable presence of sdrE is not surprising given
that strains sometimes possess a combination of two sdr genes instead of three [35].
Interestingly, the two strains which lacked sdrE exhibited slightly less baseline biofilm mass
(<0.6 mean OD at 595 nm) compared to sequenced sdrE-positive strains (>0.7 mean OD at 595
nm) (see Figure 2). The sample size in this analysis was not sufficient to make any strong
conclusions, but our findings suggest a possible relationship between biofilm establishment and
the number of sdr genes that are present in the genome.
Conclusion
SA is a major human pathogen that causes infections that are difficult to treat, resulting in
around 19,000 deaths in the U.S. each year(Sexton 2010). One factor that makes SA infections
so impervious to immune responses and drug treatment is the ability for SA to readily form
biofilms (Harriott and Noverr 2009, Suresh, Biswas et al. 2019). These communities of bacteria
are shielded from immune responses, antibiotics, and other antimicrobials via an extracellular
matrix. This extracellular matrix is typically composed of proteins, eDNA, and/or
polysaccharides(Parastan 2020). We have found, however, that biofilm composition varies
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greatly between SA strains. In this study, we examined how crystal violet binding of biofilms is
affected by the source of the strain, the presence of mecA, and the presence or absence of
biofilm-related genes. The major findings from our research were that hospital-associated SA
had a more robust biofilm, and with a greater protein composition as compared to meatassociated SA. Meat-associated SA had less robust biofilms, which had a higher eDNA
concentration. MRSA biofilms bound significantly more CV than did MSSA biofilms (Figure
1D), but there were no significant differences between DNase (Figure 4D) and proteinase K
(Figure 3D) susceptibility between MRSA and MSSA. While there were statistically significant
differences in biofilm strength and composition between meat and hospital isolates and between
MRSA and MSSA, there was so much variation in biofilm strength and composition in both
areas of comparison that these are not useful factors to predict biofilm strength or composition of
any particular strain. Mutations in certain biofilm-related genes were also found to increase
(acnA and agrA) or decrease (atl, clfA, fnbA, purH, and sarA) biofilm strength. These mutations
also affected biofilm composition as their biofilms displayed a range of polysaccharide
concentrations and susceptibility to proteinase K and DNase.
Our findings also suggest that hospital-associated SA has more protein-based biofilms
(Figure 2C) and a stronger base biofilm (Figure 2C), while meat-associated SA has more eDNAbased biofilms (Figure 4C). Past research has found MRSA biofilms to be significantly more
robust than MSSA biofilms but have not investigated how hospital and meat-associated SA
differ in biofilm formation and composition (Doulgeraki, Di Ciccio et al. 2017, RodríguezLázaro, Alonso-Calleja et al. 2018). Since environmental factors play a large role in biofilm
formation and quorum sensing, which controls gene expression within a biofilm, we wanted to
study how strains from these two different environments in which SA is commonly found,
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influence biofilm strength and composition (Cosgrove, Qi et al. 2005, Carrel, Zhao et al. 2017,
Wu, Huang et al. 2018). We found that meat isolate biofilms have a significantly greater
reduction in CV binding when treated with DNase, suggesting that meat-associated SA has, on
average, greater eDNA biofilm content when compared to hospital-associated SA. Other studies
have not looked as much into the eDNA component of biofilms but have mainly focused on
protein and polysaccharide composition (Rohde, Burandt et al. 2007, Rodríguez-Lázaro, AlonsoCalleja et al. 2018, Parastan 2020). From our results, we observed that strains which displayed
susceptibility to DNase also predominately showed susceptibility to proteinase K. Our
observations align with the findings of Graf et al. which report that cationic proteins in the ECM
are important in biofilms containing eDNA to help to stabilize the biofilm by mediating
electrostatic interactions with eDNA and anionic cell surface components (Graf, Leonard et al.
2019).
Previous studies have shown that eDNA is an important component in S. aureus biofilms
and can play a role in stability and initial attachment of the biofilm (Rice, Mann et al. 2007,
Mann, Rice et al. 2009, Sharma-Kuinkel, Mann et al. 2009). However, a study done by
Moormeier et al. found that adding DNase I within the first 8 hours of biofilm development
didn’t affect biofilm production in JE2 (the wild-type strain used in our transposon mutant
experiments) (Moormeier, Bose et al. 2014). In our experiments, we added DNase after 24 hours
of biofilm growth and observed DNase susceptibility of JE2, suggesting that DNA may be
important for stability later in biofilm development but not necessarily for initial attachment of
the biofilm in JE2. Other discrepancies have been shown in the ability of DNase I to disrupt S.
aureus biofilms, suggesting that the relative contribution of eDNA to overall stability may be
growth and strain dependent (Rice, Mann et al. 2007, Grande, Nistico et al. 2014). This is
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consistent with our results which show differences in DNase susceptibility across S. aureus
strains.
It has been proposed that MSSA biofilms are made up of primarily polysaccharides while
MRSA biofilms are made up of DNA and proteins (O'Neill, Pozzi et al. 2007, McCarthy 2015).
Our results showed much more variation in DNA, protein, and polysaccharide biofilm
components in MRSA and MSSA isolates; however, we did see that MSSA isolates, on average,
had significantly more polysaccharide in their biofilms than MRSA isolates (Figure 5D). This is
in line with the hypothesis that MSSA isolates have more polysaccharide in their biofilms than
MRSAs. We find that this model is oversimplified, however, as we largely found all three
biofilm components in both MSSA and MRSA with high variation in biochemical composition
between strains and no significant difference in average biofilm reduction when treated with
proteinase K or DNase between MSSA and MRSA (Figure3D, Figure 4D).
The mutant MRSA strains were also tested to see how specific biofilm-related genes
affect biofilm strength and composition. Mutations in atl, clfA, fnbA, purH, and sarA decreased
crystal violet-biofilm binding, suggesting decreased biofilm formation, while acnA and agrA
mutations had the opposite effect. The lacA, lacB, and malABC transposon mutants were used as
negative controls because these genes have no effect on biofilm formation (van Rooijen 1991,
Noll 2008). The icaA, icaB, and icaC transposon mutants were also used as negative controls to
confirm that the MRSA wild-type strain, JE2, produced a PIA-independent biofilm which does
not require icaABC for biofilm formation (McCarthy 2015).
These results align with previous studies that have described the importance of atl, clfA,
fnbA, and sarA for biofilm formation and development (Resch A 2005, Seidl, Goerke et al. 2008,
Yousefi, Pourmand et al. 2016, Tan, Li et al. 2018, Pisithkul T 2019). Atl in SA is reported to
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promote attachment to polystyrene surfaces and play an important role in biofilm development
(Foster 1995, Biswas, Voggu et al. 2006) Mutations in atl have shown a significant reduction in
biofilm formation similar to what our results show (Rice, Mann et al. 2007, Houston 2011,
Porayath, Suresh et al. 2018). ClfA can promote adhesion of SA to a variety of molecules and
surfaces and plays an important role in cell-cell adhesion (Tsompanidou, Denham et al. 2012).
ClfA expression appears to be highly variable in SA strains, and clfA mutations have shown
instances of biofilm reduction and changes in biofilm morphology (Dreisbach, Hempel et al.
2010, Tsompanidou, Denham et al. 2012, Wang, Cheng et al. 2017). Fibronectin binding protein,
FnBPA, allows for biofilm attachment to host cells by binding to host fibronectin (Speziale and
Pietrocola 2020). However, fnbA has been shown to play an important role in biofilm formation
even in the absence of fibronectin, highlighting the role of fibronectin binding proteins in
intercellular accumulation and not just biofilm attachment to host cell surfaces (O'Neill, Pozzi et
al. 2008, Speziale and Pietrocola 2020). We observed similar reduction in biofilm formation as
described by other studies which found mutations in fnbA to reduce biofilm formation for several
MRSA strains (O'Neill, Pozzi et al. 2008, Geoghegan, Monk et al. 2013). SarA is a quorum
regulator of SA that upregulates the expression of many virulence factors including biofilm
formation (Balamurugan, Praveen Krishna et al. 2017). Mutations in sarA have shown reduced
biofilm formation similar to what we have reported (Beenken, Blevins et al. 2003).
The acnA mutant showed a significant increase in biofilm strength which can be
explained by acnA's involvement in the TCA cycle which is known to negatively regulate
production of SA biofilms (De Backer 2018). The acnA gene has also been shown to be
downregulated in small-colony variants of SA with increased biofilm production (Sadykov M.R.
2008). The agrA mutant also showed an increase in biofilm strength. The agrA gene is an
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accessory gene regulator, and mutants of agrA are characterized by a decreased synthesis of
extracellular toxins and enzymes and an increased synthesis of cell-surface proteins which could
explain the increase in biofilm binding we saw in the agrA mutant as these cell-surface proteins
are necessary for cell attachment during biofilm formation (Janzon, Löfdahl et al. 1989,
Abdelnour, Arvidson et al. 1993, Pratten, Foster et al. 2001). Mutations of coa, purH, and ebpS
have been previously shown to be important for biofilm development in many other pathogens
but have not been tested in SA (Hadjifrangiskou, Gu et al. 2012, Yan, Yu et al. 2017). All the
gene mutants we tested supported previous studies on the importance of atl, fnbA, clfA, sarA,
acnA, and agrA genes in biofilm formation/development as well as showing the importance of
purH in S. aureus biofilm formation (Boles, Thoendel et al. 2010, Tsompanidou, Denham et al.
2012).
Previous research has looked at the effect of these gene mutations on biofilm formation
but has not investigated the effect of these genes on biofilm composition (Beenken, Blevins et al.
2003, Tu Quoc, Genevaux et al. 2007, Boles, Thoendel et al. 2010). We investigated biofilm
composition of SA mutants by looking at biofilm reduction when treated with either proteinase K
or DNase (Lauderdale, Malone et al. 2010). There were differences in proteinase K and DNase
susceptibility and polysaccharide concentrations in the tested transposon mutant biofilms,
suggesting the expression of these genes could affect the proportion of protein, DNA, and
polysaccharides in SA biofilms. We found that acnA, clfA, fnbA, and purH insertion mutants had
protein and DNA based biofilms, the agrA mutant had a predominately protein-based biofilm,
and atl and sarA mutants produced polysaccharide-based biofilms
Transposon insertions in acnA, clfA, fnbA, and purH, along with the wild-type, JE2,
showed biofilm reduction when treated with proteinase K and when separately treated with
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DNase. This is understandable as JE2 is a MRSA strain, and MRSA biofilms have been reported
to be mostly composed of mainly eDNA and proteins (Dakheel 2016). Other studies have also
observed significant biofilm reduction in MRSA strains when treated with DNase or proteinase
K (Whitchurch, Tolker-Nielsen et al. 2002, Shukla and Rao 2012, Dakheel 2016). Many proteins
play an important role in MRSA biofilm formation (Dakheel 2016, Ghasemian, Peerayeh et al.
2016). AcnA, ClfA, PurH, and FnBPA are important proteins for biofilm formation but are not
individually solely responsible for cell-to-cell attachment and interactions necessary for biofilm
formation (Dakheel 2016, Ghasemian, Peerayeh et al. 2016). This allows other biofilmassociated proteins to provide the necessary protein component despite acnA, clfA, purH, or fnbA
mutation. Strains with agrA and sarA mutations produced biofilms that were susceptible to
proteinase K treatment but not to DNase treatment. Both of these genes directly relate to quorum
sensing which allows cells to differentiate within a biofilm (Beenken, Blevins et al. 2003,
Yarwood 2004). Without these genes, the biofilm is likely not able to form a subpopulation of
cells that express autolysin genes necessary for eDNA incorporation into the biofilm. Without
the formation of this subpopulation, the biofilm may lose most of its eDNA component. Our
results found no significant biofilm reduction for the atl mutant when treated with proteinase K
or when treated with DNase, and the atl mutant produced a biofilm with significantly higher
polysaccharide concentrations than the wild-type. These results suggest that the atl mutant
produces a polysaccharide-based biofilm. This can be explained by the fact that atl is necessary
for incorporating eDNA into the biofilm (Biswas, Voggu et al. 2006, Bose 2012). Without a
functional atl gene, the mutant atl biofilm is unable to incorporate eDNA into the biofilm.
Without any DNA in the biofilm, which is used for the adhesion and structure of PIAindependent biofilms (Sugimoto, Sato et al. 2018), the atl mutant likely formed a PIA-dependent
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biofilm. This is supported by the previous observation that spontaneous switches in PIAindependent and PIA-dependent biofilms occur (Hennig S 2007, Houston 2011). MRSA strain
132 has similarly shown switching from PIA-dependent to PIA-independent biofilms (Dakheel
2016). Similar to the atl mutant, the sarA mutant also showed significantly higher polysaccharide
concentrations when compared to the wild-type, suggesting that polysaccharides may function to
stabilize the biofilm in the place of eDNA which was reduced in the sarA mutant biofilm.
Proteins SdrC, SdrD, and SdrE are rich in serine-aspartate repeats and share sequence
homology to Clf proteins expressed during colonization (Josefsson, McCrea et al. 1998).
Previous research has suggested that all SA strains maintain sdrC and at least one other gene in
the sdr locus, if not both (Peacock, Moore et al. 2002). Peacock et al. found that a certain allelic
variation of sdrE correlated with increased invasiveness and virulence in SA, which aligns with
our observation of stronger biofilm growth, associated with higher virulence, in isolates
containing sdrE (Peacock, Moore et al. 2002, Archer, Mazaitis et al. 2011).
Our results give insight into how specific isolates and genes can affect biofilm formation
and composition in SA. Future studies could further elucidate how these genes affect biofilm
formation and the mechanisms by which biofilm composition is able to change due to gene
mutations. These genes could be potential therapeutic targets for treating SA biofilm infections
and studying these genes more in depth can help us to better understand how biofilms adapt to
changing environments.
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CHAPTER III: Potential Horizontal Gene Transfer in Staphylococcus aureus Biofilms
Introduction
Staphylococcus aureus is a common gram-positive bacterium, colonizing around 30
percent of the population’s nasal passages (Lister 2014). It causes a wide range of diseases,
resulting in nearly 20,000 deaths in the United States each year (Klevens, Morrison et al. 2007,
Prevention 2019). One of the hallmarks of S. aureus is its ability to quickly and easily develop
high levels of antibiotic resistance (Stapleton and Taylor 2002). The number of antibiotic
resistant infections continues to increase each year and strains have even been discovered that
have developed resistance to vancomycin, a last resort antibiotic (Malcolm 2011, McGuinness,
Malachowa et al. 2017). Methicillin-resistant S. aureus (MRSA) are resistant to beta-lactam
antibiotics and also show an increased propensity to acquire additional antibiotic resistance genes
(Barlow 2009, Kriegeskorte and Peters 2012). MRSA infections have mostly originated from
hospitals in the past; however, there has been a large increase in community-acquired methicillin
resistant S. aureus (MRSA) infections in recent years (Malcolm 2011, Agostino, Ferguson et al.
2017). The rise in MRSA infections, particularly in otherwise healthy individuals, highlights the
importance of investigating mechanisms by which S. aureus achieves antibiotic resistance
(Kobayashi and DeLeo 2009).
S. aureus reaches high levels of antibiotic resistance at alarming rates due to its
propensity to share genes through horizontal gene transfer (HGT) (Kriegeskorte and Peters
2012). HGT occurs via three mechanisms: transformation, conjugation, and transduction. S.
aureus was previously thought to not be naturally transformable, however, recent studies have
shown that natural transformation is possible in S. aureus (Morikawa, Takemura et al. 2012,
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Maree, Nguyen et al. 2020). A study done by Maree et al. found that transformation is the main
mechanism for the spread of the Staphylococcal chromosomal cassette, SCCmecA, conferring
methicillin resistance (Maree, Nguyen et al. 2020). Although the general mechanisms of how
antibiotic resistance is derived and shared are understood, the natural environments where this
takes place and forces that drive the evolutionary process are still unclear and require further
research (Morikawa, Takemura et al. 2012).
Biofilms are known to be a hotbed for the spread of antibiotic resistance although not
much has been studied about the environmental factors within a biofilm that allow for increased
HGT and the mechanisms by which it occurs (Savage, Chopra et al. 2013). Biofilms are
communities of cells that are attached to a surface and are embedded within an extracellular
matrix (Lister 2014). The extracellular matrix is composed of polysaccharides, proteins, and
DNA, although the proportions of these components vary greatly between strains (Chaignon
2007, Whelan, Simpson et al. 2021, Ball, Augenstein et al. 2022). From our previous study
where we characterized the biofilms of meat and hospital-associated SA strains, we found that
the meat isolates showed more antibiotic resistance and had significantly higher proportions of
DNA in their biofilms when compared to the hospital isolates (Ball, Augenstein et al. 2022). This
could be due to livestock being fed a wide range of antibiotics in their feed (Cuny, Wieler et al.
2015, Smith 2015). Chronic exposure to antibiotics could have led to the evolution of livestock
associated strains to develop a more DNA-rich biofilm in order to increase the spread of
antibiotic resistance genes (Cuny, Wieler et al. 2015, Smith 2015). Due to the link between
higher levels of antibiotic resistance and higher levels of biofilm eDNA, I hypothesize that the
eDNA component of biofilms can be transformed into other cells in the biofilm, allowing for
increased HGT in biofilms with higher amounts of eDNA in their biofilms. This study seeks to
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elucidate the possible role of biofilm eDNA in horizontal gene transfer and the mechanism
behind gene transfer in SA biofilms.

Materials and Methods
Identifying Pairings and MIC Testing
S. aureus meat and hospital isolates that had been previously characterized (Ball et al.,
2022) were used in this study. Strains with complementary antibiotic resistances and
susceptibilities were paired together to test for transfer of one antibiotic resistance gene to the
other strain. (Supplementary Table 3). MIC testing was performed on strains to determine
antibiotic resistances and susceptibilities to oxacillin, tetracycline, erythromycin, clindamycin,
and chloramphenicol as outlined by the National Committee for Clinical Laboratory Standards
(Wikler 2006).
Biofilm Co-culturing Assay
Strains were grown up overnight in 3mL of TSB in a shaking incubator (37°C 200rpm).
After incubation, the culture tubes were briefly vortexed, and the cultures were diluted 1:200 by
transferring 30 µL of the overnight culture to 5.97mL of 66% TSB + 0.5% glucose. 100µL or
200µL of the diluted cultures was added into each well on a tissue treated 96 well plate (200µL
for the control wells and 100µL of both strains in the pairing for the coculturing wells). The 96
well plate was then incubated without shaking at 37°C for 24 hours. For tests with subinhibitory
concentrations of antibiotics, 2µg/mL of oxacillin and 4µg/mL of tetracycline are added to the
wells after 5 hours of incubation (antibiotic concentrations were half of the MIC).
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After the full 24 hours of incubation, the wells were dumped and lightly tapped upside down
over a paper towel to remove unattached cells from the wells. The cells in the biofilm still
attached to the wells were then resuspended in 100 µL of 1x PBS by pipetting up and down to
break up the biofilm. 10 µL from the wells was pipetted onto an LB plate with full
concentrations (MIC) of both antibiotics (4µg/mL of oxacillin and 8µg/mL of tetracycline), and
the cells were spread around half of the plate using a cell spreader. The plate was incubated
overnight at 37°C without shaking. Colonies were then counted, and potential gene transfer
efficiencies were determined by expressing the number of counted colonies as a ratio to the total
number of cells in the biofilm which was determined by plating serial dilutions. Colonies were
re-streaked onto double-antibiotic plates to confirm maintenance of the double-resistant
phenotype.
Co-culturing Assay in Shaking Cultures
Strains were grown up overnight in 3mL of TSB in a shaking incubator (37°C 200rpm).
After incubation, the culture tubes were briefly vortexed, and the cultures diluted 1:200 by
transferring 30 µL of the overnight culture to 5.97mL of 66% TSB + 0.5% glucose. 2mL of each
of the diluted strains in a pairing were added to a clean culture tube (or 4mL of a single strain for
controls). The culture tubes were then incubated in a shaking incubator at 37°C and 200rpm for
24 hours. After 5 hours of incubation, subinhibitory concentrations of antibiotics were added as
previously described. After the full 24 hours of incubation, the culture tubes were vortexed
briefly and plated onto double antibiotic plates as described above.
Transformation Assay
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Using the same pairings that showed possible HGT before, 200µL of one of the strains
and 15µL of extracted DNA (50ng/µL) from the other strain in the pairing was added to each
well in a tissue culture treated 96 well plate. (2, 5, 10, and 15 µL of 50ng/µL DNA was
originally tested but potential transformation was only detected when 15 µL of 50ng/µL DNA
was used) DNA was extracted from overnight cultures grown in 3mL of TSB (37°C and 200rpm)
using the Omega Bio-Tek DNA extraction kit. The plate was incubated at 37°C without shaking
overnight with subinhibitory antibiotics added after 5 hours of incubation as described above.
After 24 hours of incubation, the wells were dumped out by flipping the 96 well plate onto a
paper towel and tapping lightly on the wells to empty out any liquid. The cells in the biofilms
stuck to the bottom of the wells were then resuspended in 100 µL of PBS by pipetting up and
down until the cells are completely resuspended. Finally, the cell suspension was plated onto
double antibiotic plates as described in the biofilm co-culturing assay.
Results
Potential Horizontal Gene Transfer in Biofilms with Differing eDNA Content
To study the effect of biofilm eDNA concentration on potential HGT, pairings of S.
aureus isolates with differing amounts of eDNA in their biofilms were co-cultured in a biofilm,
and potential gene transfer was selected for by plating on double antibiotic plates (Figure 10A).
25% of the pairings tested displayed potential natural gene transfer in co-cultured biofilms. In
pairings with high eDNA (both strains have more than 50% biofilm reduction when treated with
DNase), there was significantly more potential HGT than in pairings with low eDNA (both
strains have less than 50% biofilm reduction when treated with DNase) (p=0.003) and medium
eDNA (one high eDNA strain and one low eDNA strain) (p=0.02).
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The same pairings were tested for potential HGT in a co-cultured biofilm in the presence
of subinhibitory levels of antibiotics (Figure 10B). Subinhibitory antibiotics increased the
number of pairings that showed potential HGT and the frequency of potential HGT. 42% of the
pairings showed potential HGT with antibiotics added. All categories of pairings (high, medium,
and low biofilm eDNA) had significantly higher frequency of gene transfer than when tested
without antibiotics added (p=0.004, p=0.04, p=0.03).
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p=0.02

p=0.019

Figure 10. Frequency of Potential Horizontal Gene Transfer in a Co-cultured
Biofilm for Pairings of Differing Biofilm eDNA Content. Average frequency of
potential horizontal gene transfer comparing pairings with high, medium, and low biofilm
eDNA tested with and without the addition of subinhibitory concentrations of antibiotics.
All pairings were tested 5 times both with and without antibiotics added.
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Potential Horizontal Gene Transfer in Shaking Cultures
The same pairings were tested in shaking cultures (Figure 11) where significantly less
potential HGT was observed than when co-cultured in a biofilm (p=0.03, p=0.007). Potential
HGT was only detected when subinhibitory concentrations of antibiotics were added to the cocultures. With antibiotics added, 25% of the pairings displayed potential HGT, however, even in
the pairings that showed potential HGT, the frequency of potential HGT was lower as well.
Similar to the biofilm co-cultures, pairings that contained strains that form high eDNA biofilms
displayed significantly more potential HGT than medium or low eDNA biofilm pairings (p=0.03,
p=0.05).

Potential Transformation of Resistance Genes in Biofilms
To investigate the mechanism of potential HGT previously observed, transformation
assays were performed which eliminated the possibility of conjugation or transduction. Isolated
DNA from one strain was added to a biofilm of another strain with opposite antibiotic
resistances, and potential HGT was selected for by plating onto double antibiotic plates. Potential
transformation was detected in 25% of the pairings without antibiotics added and 38% of the
pairings with antibiotics. Of the pairings that showed potential gene transfer where clonal
complexes (CCs) are known for both strains (see Table 2 for known CCs), 2 pairings consisted
of strains from the same CC (CC1) and one pairing contained strains from different CCs (CC1
and CC30). Differences in restriction modification systems between separate CCs greatly restrict
gene transfer between strains with different CCs (McCarthy, Witney et al. 2012, Chen,
Stephanou et al. 2016). Mutation of restriction modification genes such as hsdR, has shown
increased gene transfer between strains with different CCs (Cooper, Roberts et al. 2017). Gene
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transfer has been reported between separate lineages without hsdR mutation, suggesting gene
transfer between CCs which share similar restriction modification systems is possible (Robinson
and Enright 2004). example. the ST239 lineage derived from a CC8 background was created
through the transfer of a 550 kb SCCmec from a CC30 lineage (Robinson and Enright 2004). We
similarly observed the possibility of gene transfer between different CCs although the majority
of pairings where we observed potential gene transfer consisted of strains with the same CC.
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p=0.03
p=0.007

Figure 11. Frequency of Potential Horizontal Gene Transfer in Shaking
Co-cultures. Frequency of potential HGT was determined as a percentage
of times that potential HGT was detected out of 10 tests per pairing (5 times
with antibiotics and 5 times without). Antibiotics were needed to detect
potential HGT in any pairings. Strains that formed high DNA biofilms
showed higher frequency of potential HGT than medium and low DNA
biofilm pairings (p=0.03, p=0.05) (A). Co-cultures grown in biofilms
showed greater frequency of potential HGT than when grown in shaking
cultures (p=0.03, p=0.07) (B).
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Conclusion
Our findings reveal that HGT can potentially occur naturally in co-cultured biofilms and
that it potentially occurs at higher frequency in biofilms with higher biofilm eDNA content
(Figure 10A). Subinhibitory concentrations of antibiotics added to the biofilm were found to
significantly increase the frequency of potential HGT (Figure 10B). Co-cultured pairings grown
together in a biofilm had higher frequency of potential HGT than when grown together in
shaking cultures (Figure 11), and potential gene transfer was only detected in the shaking
cocultures in the presence of subinhibitory antibiotics. These results highlight the importance of
the biofilm environment and the eDNA component of biofilms in potential HGT in S. aureus.
The traditional belief was that S. aureus is not naturally transformable, and thus, that
transformation is not a major mechanism by which the spread of antibiotic resistance occurs in S.
aureus (Thomas and Nielsen 2005, Monk, Shah et al. 2012). In this study, transformation assays
were performed to determine investigate the potential for transformation in S. aureus biofilms.
These results, in conjunction with studies done by Maree et al. and Morikawa et al., demonstrate
that there are certain environments and circumstances where natural transformation can occur in
S. aureus, and that it is likely an important mechanism for the spread of antibiotic resistance. We
have identified several strains that exhibit natural competence including P12, C2, P21, C7, and
USA400. We are working now to confirm transformation through whole genome sequencing of
strains before and after HGT. We are also testing the veracity of our results through additional
methods. We are treating cocultured biofilms with nisin and bacitracin to see if there is a
respective increase or decrease in transformation as seen by Maree et al. Co-cultured biofilms are
also being treated with DNase to determine whether eDNA degradation potentially blocks HGT
to further confirm that the eDNA component in biofilms is necessary for gene transfer to occur.
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Subinhibitory antibiotics increased the frequency of potential HGT in all experiments
(Figure 10B, Figure 11). We are now investigating the mechanism for how antibiotics increase
potential HGT. To do so, we are testing the effect of cell wall affecting antibiotics (vancomycin
and oxacillin) and ribosome inhibitors (tetracycline and erythromycin) on potential
transformation efficiency and eDNA concentration. Antibiotics that create holes in the cell wall
could allow for more DNA to be released from the cells and/or more eDNA to be taken up into
the cell.
Colonies could arise on double antibiotic plates due to mutations, bacterial epigenetics, or
resistance mechanisms that could protect cells against an antibiotic that they would otherwise be
susceptible to (Alonso, Sanchez et al. 2001). For example, if cells with tetracycline resistance use
enzymatic inactivation of tetracycline as a resistance mechanism or if MRSA strains secrete
beta-lactamases, this could protect nearby cells that are susceptible to these antibiotics, allowing
them to grow on double antibiotic plates (Lambert 2002, Markley and Wencewicz 2018). To
control against spontaneous mutations, single strain biofilms were grown alongside co-cultures
and plated onto double antibiotic plates as well. No colonies grew for the single strain biofilm,
but colonies were detected for the co-cultures. To fully confirm that the colonies that grew on the
double antibiotic plates were a result of HGT, whole genome sequencing is needed of the two
strains in the pairing and the resulting double-resistant strain. This would not only confirm HGT
but would allow us to determine the location of the transferred resistance gene, the amount of
DNA that was transferred, and which strain was the donor, and which was the recipient.

58

CHAPTER IV: Conclusion
Together, these studies have elucidated the composition of MSSA and MRSA biofilms
and given more insight into potential mechanisms of HGT in S. aureus biofilms. I have also
identified biofilm eDNA not only as a structural component of biofilms, but also as a possible
source of gene transfer though transformation into other cells in the biofilm. These results give
us a better understanding of biofilms and HGT in biofilms to better combat difficult-to-treat S.
aureus biofilm infections and the spread of antibiotic resistance in S. aureus.
From my study characterizing the biochemical composition of S. aureus isolates from
hospitals, raw meat, and biofilm-associated gene mutants, I found that S. aureus biofilms do not
follow the traditional model proposed that MSSA biofilms are primarily polysaccharide based
and MRSA biofilms are primarily protein and DNA based (Figure 1). This model proves to be
too simplistic as much more variation in biofilm composition is present between strains. From
the 22 hospital and 32 meat isolates tested in this study, there was no significant difference in
protein or DNA biofilm content between MRSA and MSSA strains (Figure3D, Figure 4D).
Biofilm-associated mutants were also characterized by biofilm strength and composition to
clarify genes that are necessary to biofilm structure and development. These results also
demonstrate that gene expression of biofilm-associated genes acnA, agrA, atl, clfA, fnbA, purH,
and sarA are a better predictor of biofilm strength and composition than the source of isolation
and whether the strain is a MRSA or MSSA.
This study contributes to the field by demonstrating the variability of biofilm strength and
composition between individual S. aureus strains and highlighting the importance of gene
expression in biofilm strength and composition. S. aureus biofilm composition was traditionally
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thought to follow a simplified model of MSSA biofilms being composed of polysaccharides and
MRSA biofilms being composed of proteins and DNA. Our results refute this model as we found
biofilm composition to vary greatly from strain to strain. This supports many other studies that
also report a wide range of biofilm strength and composition across strains (Knobloch,
Horstkotte et al. 2002, Figueiredo, Ferreira et al. 2017, Sugimoto, Sato et al. 2018). Our study
shows that biofilm related genes affect biofilm composition. Future studies could investigate
how biofilm composition changes at different stages of biofilm development since biofilmrelated genes are differentially expressed throughout biofilm development (Spoering and
Gilmore 2006, Lister 2014).
It was previously thought that S. aureus is not naturally transformable (Thomas and
Nielsen 2005, Monk, Shah et al. 2012), however, results from recent studies in conjunction with
my results, support the idea that natural transformation is possible in S. aureus in certain
environments and conditions (Morikawa, Takemura et al. 2012, Maree, Nguyen et al. 2020). My
results demonstrate potential natural transformation in a biofilm environment, particularly in the
presence of subinhibitory levels of antibiotics although whole genome sequencing is still needed
to confirm gene transfer.
Maree et al. also investigated transformation in S. aureus biofilms (Maree, Nguyen et al.
2020). They also found that transformation efficiency increased in a biofilm environment
although they were only able to detect transformation when heat-killed cells were added to a
biofilm and not isolated DNA, which they attributed to the presence of nucleases in S. aureus
biofilms. Mature S. aureus biofilms produce nucleases, which degrade extracellular DNA, to aid
in biofilm dispersal and help protect the biofilm against host immune responses by enabling
escape from neutrophil extracellular traps (Berends, Horswill et al. 2010, Olson, Nygaard et al.
60

2013). In contrast to their results, in our study we saw potential transformation with the addition
of isolated DNA to a biofilm. This could be due to adding a larger concentration of DNA to the
biofilm. A larger concentration of eDNA would take longer for the nucleases to degrade and
could allow time for transformation to occur before eDNA degradation (Mann, Rice et al. 2009).
In addition, we used different strains from Maree et al. in our study, and differences in
transformability and gene expression between strains could also account for discrepancies
between our results and those of Maree et al.
To determine if discrepancies in our results on isolated DNA transformation in a biofilm
from the results of Maree et al. is due to differences in concentration of isolated DNA added to
the biofilm, I would test the same strains used by Maree et al. (Nef and Nef-H) and would add
the same concentration of purified genomic DNA that we added to the biofilms in our study
(15µL of 50ng/mL DNA). To further test their claims that the lack of transformation detected by
Maree et al. when adding isolated DNA to a biofilm is due to nucleases in the biofilm, the nuc
gene could be knocked out of the Nef strain to create NefΔnuc using the same approach as Maree
et al. to generate TCS deletions in Nef through double-crossover homologous recombination
using the pMADtet vector. Purified genomic DNA from donors MR-CoNS (for transformation
of mecA) and NefΔcls2-tetR (for transformation of tetR) could then be added to the biofilms as
described by Maree et al. In our study, eDNA was added to the wells before the biofilms had
formed, and because nuc expression is very low in early biofilms and much higher in mature
biofilms, this would allow for the eDNA to be incorporated into the early biofilm without
degradation by nucleases (Olson, Nygaard et al. 2013, Lister 2014). Adding eDNA at different
stages of biofilm development could further clarify whether eDNA degradation by nucleases
blocks transformation of purified genomic DNA added to a biofilm.
61

Maree et al. demonstrated gene transfer by plating cells onto antibiotic plates
(tetracycline or cefmetazole) to select for transfer of tetR or mecA. Gene transfer was then
confirmed via PCR to confirm the presence of tetR or mecA in the recipient cells. They
demonstrated transformation as the mechanism of gene transfer by using heat-killed donors
unable to synthesize conjugative machinery to eliminate the possibility of conjugation. While
many of their tested donor strains had phages, COLw/oφ (phageless) was also found to be a
successful SCCmec donor, indicating transformation as the mechanism of HGT. Transformation
efficiencies were calculated as the ratio of the number of transformants to the total CFU after
transformation. They observed SCC transformation efficiencies of up to 10−7. In our study, we
demonstrated gene transfer by plating cells onto double antibiotic plates, and gene transfer will
need to be confirmed through DNA sequencing. Since the strains used in our study have phages
and conjugative plasmids present, sequencing of possible transformants found from adding
isolated eDNA to a biofilm will determine whether doubly resistant colonies arose through
transformation. In our study, we tested potential gene transfer in co-cultures which has not been
previously tested and can be easily adapted to an in vivo model. We calculated potential
transformation efficiencies similarly to Maree et al, as a ratio of potential transformants to total
CFUs in the biofilm. We also reported transformation efficiencies of up to 10−7.
Maree et al. found that all tested factors that positively affect biofilm formation increased
transformation efficiency, such as static growth in CS2. We did not use CS2 media in our study
but used 66% TSB + 0.5% glucose which similarly facilitates biofilm formation (Lade, Park et
al. 2019). Maree et al found that com genes were necessary for gene transfer, further supporting
transformation as the mechanism of HGT. In biofilms, they found that comG mutation reduced
but did not completely abolish transformation, however, comE was required for transformation in
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a biofilm environment. Future studies for our work could investigate gene transfer using com and
atl mutants to determine whether specific com genes and/or atl is necessary for gene transfer to
occur in a co-cultured biofilm.
Nisin was found by Maree et al. to increase transformation efficiency while bacitracin
decreased transformation efficiency. We are currently investigating the effect of nisin and
bacitracin on transformation efficiencies in the pairings we have tested to see how our results
compare with those of Maree et al. We are also investigating the effect of different classes of
antibiotics on transformation efficiency and eDNA concentration. To do so, we are treating
pairings with subinhibitory concentrations of oxacillin and vancomycin (to test cell wall
inhibitors) and erythromycin and tetracycline (to test bacterial translation inhibitors).
Subinhibitory concentrations were determined through MIC testing as described in Materials and
Methods. Preliminary results demonstrate and increase in eDNA when cell wall inhibiting
antibiotics are added to both shaking cultures and biofilms. eDNA concentrations were measured
through PicoGreen staining as done by Tang et al. (Tang, Schramm et al. 2013). While an
increase in eDNA from antibiotic treatment could account for an increase in transformation
efficiency, Maree et al. suggests a role of nisin and bacitracin in gene regulation of competence
genes. To further elucidate the mechanism for increased potential transformation efficiencies
with antibiotic treatment demonstrated by our study, it would be beneficial to measure gene
expression of com genes when cells are treated with different antibiotics. This could be measured
as Maree et al. has done with nisin and bacitracin: by introducing the PcomG-gfp and PcomEdsRed dual-fluorescence reporter plasmid into Nef cells. This would allow us to measure
fluorescence to determine the expression of comG and comE in the cell in the presence of
different antibiotics. These results would show whether treatment with oxacillin, vancomycin,
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erythromycin, or tetracycline affect transformation efficiencies through altered com gene
expression.
A study done by Buzzo et al. found Z-DNA, a left-handed DNA configuration that is not
abundant intracellularly due to its high intrinsic energy state, to be an important structural
component of mature biofilms that confers nuclease-resistance (Buzzo, Devaraj et al. 2021).
They provided compelling evidence that eDNA is converted from B-form DNA (a right-handed,
low energy configuration that is the most common DNA configuration under physiologic
conditions) to Z-form DNA in a mature biofilm. While both B and Z-DNA exist in equilibrium
in a biofilm, with the equilibrium state of DNA predominantly in the B-form under native
conditions, the presence of extracellular DNABII proteins was found to shift the equilibrium of
eDNA to favor the Z-conformation and stabilize the biofilm. When chloroquine was added, the
equilibrium shifted DNA into the B-form. They also found that DNA from lysed neutrophils (Bform) can also be incorporated into the biofilm where it can also be converted into Z-form DNA
through DNABII proteins, demonstrating that foreign DNA can be fully incorporated into the
structure of the biofilm.
In our study, we added B-DNA to wells before biofilm attachment and development. This
B-DNA is what is found in the early stages of attachment and development within a biofilm
(Buzzo, Devaraj et al. 2021, York 2022). From our results, we have seen potential uptake of BDNA. Since there are differences in DNA structure in genomic DNA and biofilm eDNA, further
testing would be necessary to determine whether biofilm eDNA is transformable. To test this, the
transformation assay could be performed as described previously but instead of adding genomic
DNA extracted from an overnight shaking culture, DNA could be extracted from the ECM of a
mature biofilm. I would first grow a single strain in a biofilm for 4 days (grown in 66% TSB +
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0.5% glucose in 96 well plates at 37°C without shaking). I would then extract the ECM from the
biofilm as described in the Materials and Methods. The Omega Bio-Tek DNA extraction kit
could then be used to extract the biofilm eDNA from the ECM. This eDNA could then be added
to a biofilm and potential transformation selected for by plating cells onto double antibiotic
plates as described in the Materials and Methods section. These results could give us insights
into the effect of the B/Z eDNA equilibrium on transformation efficiency within a biofilm.
Together, our results contribute to the field by offering insights into biofilm composition
and the potential for the transfer of antibiotic resistance genes in S. aureus biofilms. Antibiotic
resistance and biofilm formation pose some of the biggest challenges to treating S. aureus
infections (DeLeo, Diep et al. 2009, Liu 2009). A great deal of research in recent years has been
attributed to attempting to understand the molecular mechanisms of S. aureus biofilm formation
and development and identifying possible sources and mechanisms for the transfer of resistance
genes in S. aureus (Lister 2014, Haaber, Penadés et al. 2017, Moormeier and Bayles 2017). Our
results elucidate the structure of the biofilm and how biofilm composition varies from strain to
strain and is dependent on the expression of biofilm-related genes. In addition, our results
support other studies in reporting a potential increase in gene transfer in the biofilm environment,
suggesting this as a source for the spread of antibiotic resistance genes (Haaber, Penadés et al.
2017, Maree, Nguyen et al. 2020). We have also shown new findings by demonstrating potential
gene transfer in co-cultured biofilms and an increase in potential gene transfer with the addition
of subinhibitory concentrations of antibiotics to the biofilm. My studies have also opened many
new avenues of study to further elucidate molecular mechanisms at play in altering biofilm
composition and clarifying the role of biofilm eDNA in HGT.
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Appendix
Supplementary Table 1. Tn mutation insertion sites. Tn insertion sites for all JE2 mutants
used. ebpS and lacB were the only genes that had over 50% of the gene functional after Tn
insertion.
mutant
gene
name
clfA

% of the gene that
is functional

forward or reverse
strand

gene length
(bp)

3

R

933

clfB

3

F

899

fnbA

4

F

1018

fnbB

14

F

940

coa

33

F

609

ebpS

90

R

486

purH

18

R

492

sarA

34

R

124

atl

32

R

1256

acnA

22

F

901

agrA

44

F

208

lacA

16

R

142

lacB

65

R

171

icaA

16

F

412

icaB

31

F

290

icaC

24

R

350

82

gene
location
(bp)
859148861950
27770392774339
26358012632744
26320632629240
266403268233
15385261537065
10679341069413
678880678505
10479891044218
13671311369837
21490742149701
23327402332311
23322962331780
28266112827850
28281152828988
28289742830027

Tn
position
859218
2776958
2635675
2631682
267000
1537208
1068204
678755
1046792
1367722
2149347
2332674
2331964
2826804
2828382
2829225

Supplementary Table 2. sdr gene distribution among SA isolates. Prevalence of sdr genes in
representative isolates. Whole genome sequence was performed on five isolates characterized in
this study, and the presence of sdrD/C/E genes was analyzed (see Materials and Methods).
Isolate

Isolate

%

Alignment

Locus

ID

type

identity

length

sdrD

USA400

MRSA

97

3772

0

sdrD

C2

MRSA

81

401

2.26E-81

sdrD

P10

MSSA

94

3780

0

sdrD

P12

MSSA

93

1783

0

sdrD

T13

MSSA

87

408

0

sdrC

USA400

MRSA

95

2875

0

sdrC

C2

MRSA

79

521

2.68E-89

sdrC

P10

MSSA

95

2028

0

sdrC

P12

MSSA

90

615

0

sdrC

T13

MSSA

86

522

3.64E-157

sdrE

USA400

MRSA

97

3258

0

sdrE

P10

MSSA

95

3258

0

sdrE

P12

MSSA

95

753

0

83

E-value

Supplementary Table 3. S. aureus pairings for coculturing assays. S. aureus strains with
opposite antibiotic resistances and susceptibilities (determined by MIC testing) were paired
together to test for the transfer of antibiotic resistance genes from one strain to the other.
Strain

DNA
content

Antibiotic
resistance

Antibiotic
susceptibility

Strain

DNA
content

Antibiotic
resistance

Antibiotic
susceptibility

C1

low

oxacillin

erythromycin

USA400

high

oxacillin

tetracycline

NS13

low

erythromycin

oxacillin

P12

high

tetracycline

oxacillin

C1

low

oxacillin

erythromycin

T4

low

oxacillin

erythromycin

C31

high

erythromycin

oxacillin

C6

high

erythromycin

oxacillin

T4

low

oxacillin

erythromycin

T6

low

oxacillin

erythromycin

C31

high

erythromycin

oxacillin

NS13

low

erythromycin

oxacillin

C20

high

oxacillin

tetracycline

T6

low

oxacillin

erythromycin

P10

low

tetracycline

oxacillin

C31

high

erythromycin

oxacillin

C2

high

oxacillin

tetracycline

T10

low

oxacillin

erythromycin

P21

high

tetracycline

oxacillin

NS13

low

erythromycin

oxacillin

C7

low

oxacillin

tetracycline

T10

low

oxacillin

erythromycin

P21

high

tetracycline

oxacillin

C6

high

erythromycin

oxacillin

C7

low

erythromycin

tetracycline

T10

low

oxacillin

erythromycin

P21

high

tetracycline

erythromycin

C31

high

erythromycin

oxacillin

C2

high

erythromycin

tetracycline

C11

low

oxacillin

erythromycin

P21

high

tetracycline

erythromycin

NS13

low

erythromycin

oxacillin

USA400

high

oxacillin

tetracycline

C11

low

oxacillin

erythromycin

SA
25923

high

tetracycline

oxacillin

C31

high

erythromycin

oxacillin

84

Strain

DNA
content

Antibiotic
resistance

Antibiotic
susceptibility

Strain

DNA
content

Antibiotic
resistance

Antibiotic
susceptibility

T4

low

oxacillin

erythromycin

C11

low

oxacillin

erythromycin

NS13

low

erythromycin

oxacillin

C31

high

erythromycin

oxacillin

USA400

high

oxacillin

tetracycline

C6

high

erythromycin

tetracycline

SA12600

high

tetracycline

oxacillin

P10

low

tetracycline

erythromycin

USA400

high

oxacillin

tetracycline

P10

low

chloramphenicol

oxacillin

SA43300

high

tetracycline

oxacillin

C7

low

oxacillin

chloramphenicol

P10

low

chloramphenicol

clindamycin

T13

low

clindamycin

chloramphenicol

85

Supplementary Figure 1. Relationship between ECM protein concentration and absolute
change in OD595 units when treated with proteinase K. ECM protein concentrations for 8 of
the hospital and meat-associated isolates were tested using the Bradford assay and were
compared to the absolute change in OD595 when treated with proteinase K for those same
isolates (R2 = 0.904). There was a significant positive correlation between the two sets of results
(Significance F< 0.01).
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Supplementary Figure 2. Relationship between ECM DNA concentration and absolute
change in OD595 units when treated with DNase. ECM DNA concentrations for 8 of the
hospital and meat-associated isolates were tested using the NanoDrop2000 and were compared to
the absolute change in OD595 when treated with DNase for those same isolates (R2 = 0.895).
There was a significant positive correlation between the two sets of results (Significance F<
0.01).
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